Cessation Therapeutics
PrivateLast Round
Grant
Oct 18, 2023
Total Funding Raised
$21.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cessation Therapeutics is a biotechnology company that develops novel immunobiologics and monoclonal antibody therapies to prevent and treat fentanyl-related overdoses.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cessation Therapeutics Comparables
Compare Cessation Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CounterX Therapeutics | 89% | |
| InterveXion | 88% | |
| ARMR Sciences Inc. | 84% |
Cessation Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 18, 2023 | ||||
| Grant | Sep 1, 2020 |
Key People
Founding team and executive leadership
Cessation Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JDH Investment Management | Initial Funding |
| Johnson & Johnson Innovation - JLABS | Initial Funding |
| Altamont Pharmaceutical Holdings | Initial Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 657% MoM, reaching 1.4K.
- Oct 18, 2023
$15M grant received from McLean Hospital.
Cessation Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cessation Therapeutics's valuation, stock price, and market status.
Is Cessation Therapeutics a public or private company?
Cessation Therapeutics is a private company.
What is the current stock price of Cessation Therapeutics?
Cessation Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Cessation Therapeutics worth (valuation)?
Valuation information for Cessation Therapeutics is not publicly available.
Can I buy Cessation Therapeutics stock?
Cessation Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cessation Therapeutics's last funding round?
Cessation Therapeutics's most recent funding round was Grant on October 18, 2023.
Who are the main investors in Cessation Therapeutics?
Key investors in Cessation Therapeutics include JDH Investment Management, Johnson & Johnson Innovation - JLABS, Altamont Pharmaceutical Holdings.
Will Cessation Therapeutics IPO soon?
No public IPO plans have been announced for Cessation Therapeutics.
How can I track Cessation Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cessation Therapeutics's secondary market activity and sign up for updates.